bluebird bio, Inc. (BLUE)
USD 5.0
(7.07%)
USD 5.0
(7.07%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 330.32 Million USD | 17.39% |
| 2022 | 281.39 Million USD | 214.11% |
| 2021 | 89.58 Million USD | -53.59% |
| 2020 | 193.02 Million USD | 1.06% |
| 2019 | 190.98 Million USD | 23.42% |
| 2018 | 154.74 Million USD | -0.68% |
| 2017 | 155.8 Million USD | 29.68% |
| 2016 | 120.14 Million USD | 94.08% |
| 2015 | 61.9 Million USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 414.34 Million USD | 25.43% |
| 2024 Q2 | 390.42 Million USD | -5.77% |
| 2023 Q4 | 330.32 Million USD | 8.76% |
| 2023 FY | 330.32 Million USD | 17.39% |
| 2023 Q3 | 303.7 Million USD | -1.03% |
| 2023 Q1 | 273.37 Million USD | -2.85% |
| 2023 Q2 | 306.85 Million USD | 12.25% |
| 2022 FY | 281.39 Million USD | 214.11% |
| 2022 Q4 | 281.39 Million USD | 1.14% |
| 2022 Q1 | 110.33 Million USD | 23.17% |
| 2022 Q3 | 278.21 Million USD | -5.04% |
| 2022 Q2 | 292.96 Million USD | 165.52% |
| 2021 FY | 89.58 Million USD | -53.59% |
| 2021 Q1 | 205.76 Million USD | 6.6% |
| 2021 Q2 | 198.6 Million USD | -3.48% |
| 2021 Q3 | 181.56 Million USD | -8.58% |
| 2021 Q4 | 89.58 Million USD | -50.66% |
| 2020 Q3 | 195.29 Million USD | -0.12% |
| 2020 Q2 | 195.51 Million USD | -2.41% |
| 2020 Q1 | 200.34 Million USD | 4.9% |
| 2020 Q4 | 193.02 Million USD | -1.16% |
| 2020 FY | 193.02 Million USD | 1.06% |
| 2019 Q2 | 194.22 Million USD | 4.55% |
| 2019 Q1 | 185.76 Million USD | 20.05% |
| 2019 Q3 | 195.95 Million USD | 0.89% |
| 2019 FY | 190.98 Million USD | 23.42% |
| 2019 Q4 | 190.98 Million USD | -2.54% |
| 2018 Q3 | 155.03 Million USD | -0.18% |
| 2018 Q4 | 154.74 Million USD | -0.19% |
| 2018 Q2 | 155.31 Million USD | -0.18% |
| 2018 Q1 | 155.59 Million USD | -0.13% |
| 2018 FY | 154.74 Million USD | -0.68% |
| 2017 Q2 | 153.96 Million USD | 4.34% |
| 2017 FY | 155.8 Million USD | 29.68% |
| 2017 Q3 | 155.05 Million USD | 0.71% |
| 2017 Q4 | 155.8 Million USD | 0.48% |
| 2017 Q1 | 147.55 Million USD | 22.82% |
| 2016 Q4 | 120.14 Million USD | 20.15% |
| 2016 FY | 120.14 Million USD | 94.08% |
| 2016 Q3 | 99.99 Million USD | 15.43% |
| 2016 Q2 | 86.62 Million USD | 16.41% |
| 2016 Q1 | 74.41 Million USD | 20.21% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 FY | 61.9 Million USD | 0.0% |
| 2015 Q4 | 61.9 Million USD | 41.4% |
| 2015 Q3 | 43.77 Million USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Caribou Biosciences, Inc. | 27.48 Million USD | -1101.841% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -53006.818% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Viracta Therapeutics, Inc. | 25.55 Million USD | -1192.558% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -137.593% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -365.405% |
| Agenus Inc. | 350.24 Million USD | 5.687% |
| Fortress Biotech, Inc. | 88.59 Million USD | -272.862% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -40761.601% |
| Novavax, Inc. | 280.63 Million USD | -17.707% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -2186.943% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -5955.472% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -1057.374% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -384.136% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -217.066% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 87.686% |
| AlloVir, Inc. | 27.42 Million USD | -1104.295% |
| Aptorum Group Limited | 3.36 Million USD | -9724.122% |
| Ardelyx, Inc. | 55.98 Million USD | -490.058% |
| Bicycle Therapeutics plc | 44.95 Million USD | -634.776% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -225.817% |
| Chimerix, Inc. | 2.14 Million USD | -15306.996% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -1481.7% |
| CRISPR Therapeutics AG | 238.63 Million USD | -38.425% |
| Clearside Biomedical, Inc. | 43 Million USD | -668.182% |
| Precision BioSciences, Inc. | 31.26 Million USD | -956.435% |
| Dyadic International, Inc. | 136.92 Thousand USD | -241138.89% |
| Elevation Oncology, Inc. | 30.13 Million USD | -996.081% |
| Fortress Biotech, Inc. | 88.59 Million USD | -272.862% |
| GT Biopharma, Inc. | 58 Thousand USD | -569427.586% |
| Alkermes plc | 290.73 Million USD | -13.62% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Innoviva, Inc. | 449.07 Million USD | 26.443% |
| IO Biotech, Inc. | 2.49 Million USD | -13144.828% |
| Jaguar Health, Inc. | 35.86 Million USD | -821.154% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -5258.086% |
| ContextLogic Inc. | 6 Million USD | -5405.433% |
| AbCellera Biologics Inc. | 77.38 Million USD | -326.888% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -140781.388% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -186.814% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -181.865% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -2445.669% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -199.322% |
| NextCure, Inc. | 6.6 Million USD | -4901.151% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -4936.225% |
| ChromaDex Corporation | 3.27 Million USD | -9980.134% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -11401.602% |
| Incyte Corporation | 38.28 Million USD | -762.763% |
| Opthea Limited | 200.62 Million USD | -64.645% |
| MiMedx Group, Inc. | 48.09 Million USD | -586.763% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -829.049% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -4602.819% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -4213.816% |
| Vaxcyte, Inc. | 29.22 Million USD | -1030.324% |
| PDS Biotechnology Corporation | 23.85 Million USD | -1284.921% |
| Pharming Group N.V. | 171.54 Million USD | -92.559% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Onconetix, Inc. | 9.88 Million USD | -3241.428% |
| Acelyrin, Inc. | 1.19 Million USD | -27565.494% |
| PureTech Health plc | 25.51 Million USD | -1194.787% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -1448.573% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -3252.883% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -73212.752% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -411121.492% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -445.281% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Seer, Inc. | 28.25 Million USD | -1068.923% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -766.906% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -36359.823% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -19883.424% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -113945.912% |
| Summit Therapeutics Inc. | 106.09 Million USD | -211.338% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -5220.973% |
| Senti Biosciences, Inc. | 37.66 Million USD | -776.987% |
| ImmuCell Corporation | 11.96 Million USD | -2659.776% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -432.14% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -1245.962% |
| Precigen, Inc. | 7.09 Million USD | -4554.446% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -69442.316% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -103776.101% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -4732.86% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | -44.127% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -326955.446% |
| Sorrento Therapeutics, Inc. | 134.5 Million USD | -145.588% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -625.832% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -15481.415% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -154257.944% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -1862.721% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -928.476% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -219.045% |
| TRACON Pharmaceuticals, Inc. | 968 Thousand USD | -34024.587% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | -57.193% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -9186.646% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -19480.676% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -109747.23% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -1219.088% |
| Aptose Biosciences Inc. | 1 Million USD | -32611.828% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -3816050.647% |
| Soligenix, Inc. | 3.49 Million USD | -9352.575% |
| Century Therapeutics, Inc. | 48.17 Million USD | -585.736% |
| Kura Oncology, Inc. | 17.2 Million USD | -1820.5% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -257.368% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -208967.089% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -15264.0% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -2263.861% |
| Autolus Therapeutics plc | 52.96 Million USD | -523.645% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -5939.971% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -689.441% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | -43.976% |
| GRI Bio, Inc. | 14 Thousand USD | -2359371.429% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -2558.773% |
| IGM Biosciences, Inc. | 40.5 Million USD | -715.499% |
| INmune Bio, Inc. | 10.43 Million USD | -3064.952% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -83.894% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -5492.055% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -404314.789% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -39850.22% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -538.003% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -466.782% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -470.787% |
| Coherus BioSciences, Inc. | 480.84 Million USD | 31.303% |
| Verastem, Inc. | 41.55 Million USD | -694.875% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -6017.148% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -2804.731% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -3266.208% |
| Histogen Inc. | 4.62 Million USD | -7046.82% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 3.37 Million USD | -9675.851% |
| Organovo Holdings, Inc. | 1.39 Million USD | -23596.27% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 46 Million USD | -618.073% |
| Panbela Therapeutics, Inc. | 5.19 Million USD | -6259.761% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -1455.28% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -1547094.379% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -290.512% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -157935.595% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -993.216% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -203406.718% |
| Apollomics, Inc. | 4.66 Million USD | -6987.02% |
| Amarin Corporation plc | 8.73 Million USD | -3680.771% |
| Mesoblast Limited | 118.92 Million USD | -177.765% |
| Turnstone Biologics Corp. | 3.21 Million USD | -10177.722% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -290.115% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -133635.223% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -238.424% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -73.907% |
| Better Therapeutics, Inc. | 14.88 Million USD | -2119.933% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -979.003% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -197.784% |
| NLS Pharmaceutics AG | 1.63 Million USD | -20118.932% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 6.13 Million USD | -5288.679% |
| Gritstone bio, Inc. | 104.77 Million USD | -215.272% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -11756.64% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -675827.972% |
| Avid Bioservices, Inc. | 207.83 Million USD | -58.937% |
| Insmed Incorporated | 1.2 Billion USD | 72.564% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.71 Million USD | -4822.158% |
| OmniAb, Inc. | 25.56 Million USD | -1192.305% |
| Alector, Inc. | 38.91 Million USD | -748.774% |
| Seres Therapeutics, Inc. | 213.93 Million USD | -54.404% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 15.15 Million USD | -2080.226% |
| Revance Therapeutics, Inc. | 478.43 Million USD | 30.957% |
| Aura Biosciences, Inc. | 19.55 Million USD | -1589.042% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -422.941% |
| Immunic, Inc. | 1.33 Million USD | -24662.069% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -940.987% |
| Veracyte, Inc. | 12.63 Million USD | -2515.408% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 48.776% |
| FibroGen, Inc. | 170.45 Million USD | -93.791% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -3537.551% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -161895.184% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 94.301% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -892672.973% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -7696.224% |
| TG Therapeutics, Inc. | 110.79 Million USD | -198.142% |
| Galecto, Inc. | 249 Thousand USD | -132561.044% |
| Calithera Biosciences, Inc. | 1.66 Million USD | -19727.491% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 80.314% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -4414.5% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -6020.548% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -11756.64% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -1128.846% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -632.869% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -23178.788% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -630.228% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -665.193% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -584.912% |
| Vaxxinity, Inc. | 15.16 Million USD | -2077.782% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 61.079% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -32051.708% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -2915.299% |
| NexImmune, Inc. | 68.8 Thousand USD | -479962.201% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -2327122.77% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 87.779% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -84166.407% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -4683.174% |
| Ainos, Inc. | 5.96 Million USD | -5439.078% |
| Pluri Inc. | 29.61 Million USD | -1015.514% |
| Prothena Corporation plc | 11.83 Million USD | -2691.094% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -1208.999% |
| Celularity Inc. | 65.41 Million USD | -404.954% |
| Rallybio Corporation | 392 Thousand USD | -84166.837% |
| Cue Biopharma, Inc. | 14.69 Million USD | -2147.88% |
| MeiraGTx Holdings plc | 89.26 Million USD | -270.055% |
| Omeros Corporation | 338.28 Million USD | 2.352% |
| Humacyte, Inc. | 58.1 Million USD | -468.489% |
| Immunocore Holdings plc | 84.03 Million USD | -293.095% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -17726.552% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -6673.139% |
| Blueprint Medicines Corporation | 774.12 Million USD | 57.329% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -6482.822% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -434.352% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -217.328% |
| Pulmatrix, Inc. | 8.75 Million USD | -3672.567% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -4675.567% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -2285.025% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -186.378% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -947.058% |
| Cytokinetics, Incorporated | 755.77 Million USD | 56.293% |
| Eloxx Pharmaceuticals, Inc. | 13.38 Million USD | -2368.066% |
| Nutriband Inc. | 241.28 Thousand USD | -136802.833% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -5942.18% |
| Vor Biopharma Inc. | 35.66 Million USD | -826.321% |
| Roivant Sciences Ltd. | 499.74 Million USD | 33.902% |
| Evogene Ltd. | 1.13 Million USD | -28926.889% |
| ProKidney Corp. | 4.41 Million USD | -7385.293% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -26843.393% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -598696.338% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 81.014% |
| CorMedix Inc. | 667.63 Thousand USD | -49377.257% |
| BioLineRx Ltd. | 11.59 Million USD | -2749.849% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -748.731% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -360.019% |
| Atai Life Sciences N.V. | 16.47 Million USD | -1904.892% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -13377.215% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -48837.185% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -621.661% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -508093.846% |
| MediciNova, Inc. | 215.92 Thousand USD | -152881.114% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -13139.519% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -26094.977% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -77.24% |
| Biomea Fusion, Inc. | 10.29 Million USD | -3108.294% |
| PTC Therapeutics, Inc. | 415.02 Million USD | 20.408% |
| Mereo BioPharma Group plc | 5.95 Million USD | -5449.832% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -9101.281% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -20103.425% |
| Absci Corporation | 15.95 Million USD | -1970.101% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -3505.785% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -2151.557% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -1104.91% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -2594.779% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -2541.34% |
| Allakos Inc. | 41.46 Million USD | -696.638% |
| Imunon, Inc. | 1.62 Million USD | -20231.332% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -2952.638% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -218658.94% |
| BioAtla, Inc. | 2.46 Million USD | -13327.886% |
| NLS Pharmaceutics AG | 1.63 Million USD | -20118.932% |
| Bio-Path Holdings, Inc. | 113 Thousand USD | -292223.894% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -247.269% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -5856.113% |
| XOMA Corporation | 124.45 Million USD | -165.429% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -1644.71% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -665.228% |
| aTyr Pharma, Inc. | 15.09 Million USD | -2088.314% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -2865.757% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -1168.387% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -1469.394% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -94549.284% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -101073.991% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -20143.975% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 77.967% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -201358.83% |
| UroGen Pharma Ltd. | 100.21 Million USD | -229.621% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -80.754% |
| ZIVO Bioscience, Inc. | 346.34 Thousand USD | -95275.669% |
| Orgenesis Inc. | 22.62 Million USD | -1360.263% |
| Entera Bio Ltd. | 390 Thousand USD | -84598.974% |
| GH Research PLC | 343 Thousand USD | -96204.956% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -108203.607% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -33849.229% |
| Xencor, Inc. | 83.43 Million USD | -295.913% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -191201.477% |
| Replimune Group, Inc. | 75.86 Million USD | -335.39% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -26882.436% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -3412.612% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -201358.83% |
| Portage Biotech Inc. | 47 Thousand USD | -702721.277% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -26094.977% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -13566.777% |
| OncoCyte Corporation | 2.86 Million USD | -11413.628% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -25325.026% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -219306.99% |
| Purple Biotech Ltd. | 351 Thousand USD | -94009.972% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -10356.664% |
| scPharmaceuticals Inc. | 40.26 Million USD | -720.298% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 51.19 Million USD | -545.256% |
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -232523.944% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -6214.777% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -1135.418% |
| Curis, Inc. | 2.79 Million USD | -11722.691% |
| Daré Bioscience, Inc. | 5.31 Million USD | -6111.301% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -15361.45% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -58364.779% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -1874.335% |
| BeiGene, Ltd. | 930.18 Million USD | 64.488% |
| Kiromic BioPharma, Inc. | 15.54 Million USD | -2025.308% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -275.609% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -28850.57% |
| Erasca, Inc. | 55.85 Million USD | -491.357% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 70.868% |
| DBV Technologies S.A. | 14.38 Million USD | -2196.961% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -13102.478% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 12.23 Million USD | -2600.948% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -7012.963% |
| Travere Therapeutics, Inc. | 404.78 Million USD | 18.395% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -617.492% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -7066.978% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -12894.729% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -1652.114% |
| MacroGenics, Inc. | 33.97 Million USD | -872.376% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 20.92 Million USD | -1478.694% |
| Prime Medicine, Inc. | 13.63 Million USD | -2322.988% |
| Aditxt, Inc. | 18.21 Million USD | -1713.186% |
| Adagene Inc. | 22.3 Million USD | -1380.826% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -2058.57% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 45.934% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -1527.783% |
| SciSparc Ltd. | 76 Thousand USD | -434539.474% |
| Vericel Corporation | 88.14 Million USD | -274.761% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -302.754% |
| Generation Bio Co. | 97.89 Million USD | -237.432% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -100303.04% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -1205.74% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -60.418% |
| Invivyd, Inc. | 2.16 Million USD | -15157.552% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -517.824% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -9374227.772% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -5859.336% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -524226.984% |
| 2seventy bio, Inc. | 256.67 Million USD | -28.695% |
| ADMA Biologics, Inc. | 141.41 Million USD | -133.581% |
| Clene Inc. | 32.16 Million USD | -927.101% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -5785.904% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -14949.021% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -551.891% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -68539.882% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -70.983% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 30.12 Million USD | -996.481% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -1820.835% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -165.237% |
| Evaxion Biotech A/S | 10.86 Million USD | -2938.967% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -296.127% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -340.981% |
| Trevena, Inc. | 35.23 Million USD | -837.547% |
| Surrozen, Inc. | 3.37 Million USD | -9675.851% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -4985.068% |
| Cingulate Inc. | 3.13 Million USD | -10436.382% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -805573.171% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -1123.883% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -65846.101% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -54680.431% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -477.443% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -70937.849% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 28.27 Million USD | -1068.386% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -1533.741% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -21142.83% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -26116.349% |
| Statera Biopharma, Inc. | 16.26 Million USD | -1931.383% |
| ImmunityBio, Inc. | 883.67 Million USD | 62.619% |
| Korro Bio, Inc. | 33.2 Million USD | -894.748% |
| Kineta, Inc. | 1.31 Million USD | -24981.701% |
| BioVie Inc. | 6.11 Million USD | -5305.037% |
| Codexis, Inc. | 22.36 Million USD | -1377.043% |
| Celularity Inc. | 65.41 Million USD | -404.954% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -538.583% |
| Celcuity Inc. | 37.44 Million USD | -782.133% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -147169.728% |
| Cibus, Inc. | 24.62 Million USD | -1241.643% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -86146.997% |
| eFFECTOR Therapeutics, Inc. | 19.44 Million USD | -1598.771% |
| IN8bio, Inc. | 4.89 Million USD | -6650.991% |
| Kodiak Sciences Inc. | 181.63 Million USD | -81.866% |
| Annexon, Inc. | 31.35 Million USD | -953.503% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -340.223% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -14004.441% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -8363.387% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 77.274% |
| Eyenovia, Inc. | 16.1 Million USD | -1950.726% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -196.283% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -33435.635% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -2783.181% |
| Arcellx, Inc. | 97.62 Million USD | -238.362% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -15271.149% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -1145.902% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -10548.807% |
| Moolec Science SA | 2.64 Million USD | -12387.331% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -1059.568% |
| Geron Corporation | 85.89 Million USD | -284.552% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -5132.473% |
| Royalty Pharma plc | 6.13 Billion USD | 94.616% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -13652.123% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -286506.972% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -876.429% |
| Humacyte, Inc. | 58.1 Million USD | -468.489% |
| Structure Therapeutics Inc. | 5.45 Million USD | -5957.692% |
| 89bio, Inc. | 27.1 Million USD | -1118.555% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -2386.271% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -13013.378% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -24588.042% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -211.44% |
| Notable Labs, Ltd. | 2.04 Million USD | -16021.327% |
| Liquidia Corporation | 3.5 Million USD | -9329.803% |
| Mustang Bio, Inc. | 2.49 Million USD | -13123.619% |
| Immunovant, Inc. | 138 Thousand USD | -239266.667% |
| Quantum-Si incorporated | 15.3 Million USD | -2058.57% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -3687.708% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -82481.5% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -515.041% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -404314.789% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -2929.68% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -156832.666% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -162622.167% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -1498.79% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -81866.749% |
| PepGen Inc. | 20.1 Million USD | -1543.086% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -57448.084% |
| United Therapeutics Corporation | 700 Million USD | 52.811% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 26.26 Million USD | -1157.666% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.46 Million USD | -7301.502% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 886 Thousand USD | -37182.844% |
| XOMA Corporation | 124.45 Million USD | -165.429% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -120456.934% |
| Bionomics Limited | 239.61 Million USD | -37.855% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -16140.224% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -2388.144% |
| uniQure N.V. | 138.4 Million USD | -138.659% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -286.694% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -31908.333% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -33435.635% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -3537.551% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -18808.185% |
| Altimmune, Inc. | 671 Thousand USD | -49128.912% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | 25.779% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -2388.144% |
| Compugen Ltd. | 1.35 Million USD | -24350.481% |
| Peak Bio, Inc. | 10.72 Million USD | -2980.88% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -672.403% |
| Benitec Biopharma Inc. | 284 Thousand USD | -116211.972% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -290.664% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -1558.18% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 11.77 Million USD | -2704.364% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -261.178% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -1558.18% |
| Instil Bio, Inc. | 86.05 Million USD | -283.859% |
| argenx SE | 20 Million USD | -1551.63% |
| Immunome, Inc. | 1.65 Million USD | -19919.758% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -18960.935% |
| Verona Pharma plc | 51.32 Million USD | -543.547% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -3278.257% |
| Shattuck Labs, Inc. | 4.2 Million USD | -7761.161% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -91150.276% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -7800.646% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -56365.983% |
| Moolec Science SA | 2.64 Million USD | -12387.331% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -993.46% |
| AnaptysBio, Inc. | 17.81 Million USD | -1754.306% |
| Design Therapeutics, Inc. | 3.05 Million USD | -10730.361% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -125978.626% |
| NeurAxis, Inc. | 224.26 Thousand USD | -147195.996% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -2221.662% |
| Lumos Pharma, Inc. | 6.58 Million USD | -4916.34% |
| Achilles Therapeutics plc | 4.61 Million USD | -7057.66% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -3278.257% |
| 180 Life Sciences Corp. | 1.32 Million USD | -24923.389% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -1833.979% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -21142.83% |
| Nutriband Inc. | 241.28 Thousand USD | -136802.833% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -3134.368% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -39891.041% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | 11.612% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -997.465% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -8832.882% |
| Palisade Bio, Inc. | 369 Thousand USD | -89419.241% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -79496.627% |
| Beam Therapeutics Inc. | 173.17 Million USD | -90.749% |
| Neurogene Inc. | 16.25 Million USD | -1932.15% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | -7.199% |
| AEON Biopharma, Inc. | 278 Thousand USD | -118722.302% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -98504.776% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -308930.695% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -335.43% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -440.57% |
| Athira Pharma, Inc. | 1.58 Million USD | -20740.757% |
| Vaccinex, Inc. | 247 Thousand USD | -133635.223% |
| HCW Biologics Inc. | 6.45 Million USD | -5019.923% |
| XOMA Corporation | 124.45 Million USD | -165.429% |
| Nektar Therapeutics | 230.4 Million USD | -43.37% |
| Arvinas, Inc. | 3.4 Million USD | -9615.471% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -20143.975% |
| Merus N.V. | 12.16 Million USD | -2616.05% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -157.207% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -2291.241% |
| Rezolute, Inc. | 2.22 Million USD | -14726.122% |
| Clene Inc. | 32.16 Million USD | -927.101% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -188600.565% |
| BeyondSpring Inc. | 3.99 Million USD | -8168.486% |
| Synlogic, Inc. | 17.27 Million USD | -1812.162% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -25309.692% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -943688.571% |
| Peak Bio, Inc. | 10.72 Million USD | -2980.88% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -536.184% |
| Krystal Biotech, Inc. | 8.09 Million USD | -3981.122% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -86.608% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -4580.828% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -241730.534% |
| MannKind Corporation | 382.37 Million USD | 13.613% |
| Ikena Oncology, Inc. | 10.73 Million USD | -2976.234% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -80664.303% |
| Gossamer Bio, Inc. | 212.46 Million USD | -55.474% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -189742.529% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -3505.785% |
| Legend Biotech Corporation | 328.67 Million USD | -0.503% |
| Mural Oncology plc | 15 Million USD | -2100.853% |
| Biora Therapeutics, Inc. | 47.42 Million USD | -596.508% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 2.1 Million USD | -15622.323% |
| Champions Oncology, Inc. | 7.43 Million USD | -4345.841% |
| REGENXBIO Inc. | 89.29 Million USD | -269.947% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -38548.316% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -59635.398% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -6001.33% |
| Vaxart, Inc. | 26.51 Million USD | -1145.855% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -2009.717% |
| Cellectis S.A. | 92.85 Million USD | -255.752% |
| Longeveron Inc. | 2.04 Million USD | -16084.517% |
| Repare Therapeutics Inc. | 3.41 Million USD | -9586.979% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 76.351% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -608.976% |
| Revolution Medicines, Inc. | 87.94 Million USD | -275.609% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -190839.884% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -8256.337% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -104103.785% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -188657.714% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 59.138% |
| Denali Therapeutics Inc. | 52.24 Million USD | -532.312% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -2193.061% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -23941.194% |
| Cingulate Inc. | 3.13 Million USD | -10436.382% |
| Passage Bio, Inc. | 26.29 Million USD | -1156.279% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -4856.129% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -80862.255% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -36849.217% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -1506.566% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -26116.349% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -13376.528% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -10477.201% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -40630.703% |
| OmniAb, Inc. | 25.56 Million USD | -1192.305% |
| Anew Medical, Inc. | 1.6 Million USD | -20481.059% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -1016.613% |
| Lipocine Inc. | 17.16 Thousand USD | -1924203.856% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -2738.34% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -853.927% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -5492.055% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -477.766% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -162622.167% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -6295.47% |
| Ocugen, Inc. | 6.94 Million USD | -4659.055% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -2237.929% |
| Q32 Bio Inc. | 1.31 Million USD | -24962.671% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -49055.655% |
| Alumis Inc. Common Stock | 32.58 Million USD | -913.892% |
| Equillium, Inc. | 824 Thousand USD | -39988.107% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -3538.352% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -109713.634% |
| Galera Therapeutics, Inc. | 152.29 Million USD | -116.893% |
| Evelo Biosciences, Inc. | 51.13 Million USD | -545.95% |
| Comera Life Sciences Holdings, Inc. | 775.04 Thousand USD | -42520.07% |
| Dominari Holdings Inc. | 3.02 Million USD | -10809.049% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -349499.416% |
| vTv Therapeutics Inc. | 529 Thousand USD | -62343.478% |
| Bio-Techne Corporation | 419.53 Million USD | 21.264% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -358.812% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -70.653% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -1855.981% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -1351.217% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -5352.724% |
| Nkarta, Inc. | 88.33 Million USD | -273.93% |
| BioCardia, Inc. | 1.31 Million USD | -25019.848% |
| Iterum Therapeutics plc | 19.5 Million USD | -1593.198% |